TB-402
TB-402, a human IgG4 anticoagulant monoclonal antibody, is a partial Factor VIII inhibitor. TB-402 has a prolonged antithrombotic effect. TB-402 can be used for the prevention of venous thromboembolism (VTE) after total knee replacement (TKR) [1].
Product Specifications
UNSPSC
12352203
Target
Factor VIII
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
References & Citations
[1]Verhamme P, et al. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J Thromb Haemost. 2011 Apr;9 (4) :664-71.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2804254-01 48 Tests
Canine Tissue inhibitors of metalloproteinase 1 (TIMP-1) ELISA Kit
Sign In for Pricing
View Details MBS2804254-02 96 Tests
Canine Tissue inhibitors of metalloproteinase 1 (TIMP-1) ELISA Kit
Sign In for Pricing
View Details MBS2804254-03 5x 96 Tests
Canine Tissue inhibitors of metalloproteinase 1 (TIMP-1) ELISA Kit
Sign In for Pricing
View Details MBS2804254-04 10x 96 Tests
Canine Tissue inhibitors of metalloproteinase 1 (TIMP-1) ELISA Kit
Sign In for Pricing
View Details